Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Sun, Hwa Yeon | - |
dc.contributor.author | Choi, Hoon | - |
dc.contributor.author | Park, Jae Young | - |
dc.contributor.author | Bae, Jae Hyun | - |
dc.contributor.author | Doo, Seung Whan | - |
dc.contributor.author | Yang, Won Jae | - |
dc.contributor.author | Song, Yun Seob | - |
dc.contributor.author | Ko, Young Myoung | - |
dc.contributor.author | Kim, Jae Heon | - |
dc.date.accessioned | 2021-09-03T10:58:04Z | - |
dc.date.available | 2021-09-03T10:58:04Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-01-10 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/84931 | - |
dc.description.abstract | Background There is still controversy as to whether initial combination treatment is superior to serial addition of anticholinergics after maintenance or induction of alpha blockers in benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) Objective The objective of this study was to determine the benefits and safety of initial combination treatment of an alpha blocker with anticholinergic medication in BPH/LUTS through a systematic review and meta-analysis. Methods We conducted a meta-analysis of improvement in LUTS using International Prostate Symptom Score (IPSS), maximal urinary flow rate (Qmax), post-voided residual volume (PVR), and quality of life (QoL). Results In total, 16 studies were included in our analysis, with a total sample size of 3,548 subjects (2,195 experimental subjects and 1,353 controls). The mean change in total IPSS improvement from baseline in the combination group versus the alpha blocker monotherapy group was -0.03 (95% CI: -0.14-0.08). The pooled overall SMD change of storage IPSS improvement from baseline was -0.28 (95% CI: -0.40 - -0.17). The pooled overall SMD changes of QoL, Qmax, and PVR were -0.29 (95% CI: -0.50 - -0.07), 0.00 (95% CI: -0.08-0.08), and 0.56 (95% CI: 0.23-0.89), respectively. There was no significant difference in the number of acute urinary retention (AUR) events or PVR. Conclusions Initial combination treatment of an alpha blocker with anticholinergic medication is efficacious for in BPH/LUTS with improved measures such as storage symptoms and QoL without causing significant deterioration of voiding function. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.subject | TOLTERODINE EXTENDED-RELEASE | - |
dc.subject | CONTROLLED ABSORPTION SYSTEM | - |
dc.subject | OVERACTIVE BLADDER SYMPTOMS | - |
dc.subject | PROPIVERINE HYDROCHLORIDE | - |
dc.subject | CLINICAL GUIDELINES | - |
dc.subject | OUTLET OBSTRUCTION | - |
dc.subject | STORAGE SYMPTOMS | - |
dc.subject | COMBINED THERAPY | - |
dc.subject | SINGLE-TABLET | - |
dc.subject | MEN | - |
dc.title | Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Jung | - |
dc.contributor.affiliatedAuthor | Choi, Hoon | - |
dc.contributor.affiliatedAuthor | Park, Jae Young | - |
dc.contributor.affiliatedAuthor | Bae, Jae Hyun | - |
dc.identifier.doi | 10.1371/journal.pone.0169248 | - |
dc.identifier.scopusid | 2-s2.0-85009069297 | - |
dc.identifier.wosid | 000391844200011 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.12, no.1 | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | TOLTERODINE EXTENDED-RELEASE | - |
dc.subject.keywordPlus | CONTROLLED ABSORPTION SYSTEM | - |
dc.subject.keywordPlus | OVERACTIVE BLADDER SYMPTOMS | - |
dc.subject.keywordPlus | PROPIVERINE HYDROCHLORIDE | - |
dc.subject.keywordPlus | CLINICAL GUIDELINES | - |
dc.subject.keywordPlus | OUTLET OBSTRUCTION | - |
dc.subject.keywordPlus | STORAGE SYMPTOMS | - |
dc.subject.keywordPlus | COMBINED THERAPY | - |
dc.subject.keywordPlus | SINGLE-TABLET | - |
dc.subject.keywordPlus | MEN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.